Geneos Wealth Management’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-56
Closed -$2.52K – 2879
2025
Q2
$2.52K Buy
56
+13
+30% +$536 ﹤0.01% 2762
2025
Q1
$1.69K Buy
43
+12
+39% +$538 ﹤0.01% 2812
2024
Q4
$1.44K Hold
31
– – ﹤0.01% 2682
2024
Q3
$1.63K Buy
+31
New +$1.54K ﹤0.01% 2341
2022
Q2
– Sell
-15
Closed -$1K – 2699
2022
Q1
$1K Buy
+15
New +$1.17K ﹤0.01% 2665

Other funds holding LIVN

Geneos Wealth Management's LIVN Position: Q3 2025 in Review

Geneos Wealth Management sold out of LivaNova (LIVN) in Q3 2025, closing a stake of 56 shares — an estimated $2.52K sold.

Geneos Wealth Management first reported a position in LIVN in Q1 2022 and held it in 5 quarters. The position peaked at $2.52K in Q2 2025. 271 funds tracked by Wall St. Rank hold LIVN as of Q3 2025.

  • Geneos Wealth Management reported no remaining LivaNova position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 56 LivaNova shares in Q3 2025, an estimated $2.52K.
  • Geneos Wealth Management first reported a position in LivaNova in Q1 2022 and held it in 5 quarters.
  • Geneos Wealth Management's LivaNova position peaked at $2.52K in Q2 2025.
  • 271 funds tracked by Wall St. Rank held LivaNova as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.